FDC
Back to Cashflow Statement
|
FDC Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-92 Cr | ₹-202 Cr | ₹-180 Cr | ₹-9.84 Cr | ₹-129 Cr |
What is the latest Cash Flow from Financing Activities ratio of FDC ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-92 Cr |
| Mar2024 | ₹-202 Cr |
| Mar2023 | ₹-180 Cr |
| Mar2022 | ₹-9.84 Cr |
| Mar2021 | ₹-129 Cr |
How is Cash Flow from Financing Activities of FDC Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-92 Cr | Negative | |
| Mar2024 | ₹-202 Cr | Negative | |
| Mar2023 | ₹-180 Cr | Negative | |
| Mar2022 | ₹-9.84 Cr | Negative | |
| Mar2021 | ₹-129 Cr | - | |
Compare Cash Flow from Financing Activities of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹5,600.3 Cr | -1.7% | -16.1% | -26.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,952.0 Cr | 1.8% | -1.6% | 16.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹230,427.0 Cr | -1.2% | 17.3% | 38.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,141.0 Cr | -2.3% | -2% | 33.6% | Stock Analytics | |
| CIPLA | ₹114,715.0 Cr | 0.2% | 1.7% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,409.9 Cr | 1.2% | 3.6% | -7% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | -1.7% |
-16.1% |
-26.9% |
| SENSEX | -0.5% |
1.3% |
-4% |
You may also like the below Video Courses